Infection Surveillance Solutions Market Analysis Report By End Use (Hospitals, Care Centers), By Product and Services, By Infection (Surgical Site, Urinary Tract, Blood Stream), And Segment Forecasts, 2018 - 2026

Report Overview

The global infection surveillance solutions market size was valued at USD 303.7 million in 2017. Increasing prevalence of hospital-acquired infections (HAIs), rising resistance of microbes towards antibiotics, and growing use of automation in healthcare settings are some of the primary trends escalating market growth during the forecast period. However, the high cost of these solutions along with the dearth of skilled healthcare IT professionals can inhibit the growth of the market.

According to estimates provided by the Centers for Disease Control and Prevention (CDC), each year, drug-resistant bacteria cause more than 23,000 deaths and make approximately 2.0 million people sick in the U.S. alone. Moreover, according to the California Department of Public Health (CDPH), in 2016, 18,924 HAI cases were reported in 400 acute care hospitals. As per statistics published by the European Commission (EC), around 25,000 people die in the European Union (EU) from antibiotic-resistant bacteria annually. If the current infection trend continues until 2050, it is anticipated to increase to 10 million deaths per year, globally.

Rise in the number of surgeries performed worldwide has led to increased stays in hospitals. As a result, the number of cases of patients suffering from HAIs is slated to increase. This is estimated to work in favor of the market. Growing expenditure on healthcare is also expected to stir up the demand for infection surveillance solutions.

Moreover, favorable government initiatives have also been contributing to the growth of the market. For instance, Canada-based National Microbiology Laboratory (NML) and Public Health Agency of Canada's Centre for Communicable Diseases and Infection Control (CCDIC) introduced the Canadian Nosocomial Infection Surveillance Program (CNISP) to provide prevalence rate and trends of HAIs at Canadian healthcare facilities. As of now, 54 hospitals participate in the CNISP network.

Product and Service Insights

On the basis of product and services, the market has been classified into software and services. The software segment is further categorized into on-premise and web-based software. In 2017, the software segment led the market. On the other hand, the services segment is projected to exhibit a higher CAGR during the forecast period due to the higher adoption of software packages in healthcare facilities.

The web-based software is anticipated to witness the highest CAGR during the forecast period. The growth of the sub-segment can be attributed to its advantages over on-premise software such as availability in different configurations, rapid return on investment, and real-time analysis. Moreover, healthcare IT companies come up with innovative solutions in data management, analytics, and infrastructure that makes data collection of electronic health records (EHR), infection, and epidemic trends easier through their software packages.

Infection Type Insights

Based on infection type, the infection surveillance solutions market has been segmented into surgical site infections (SSI), bloodstream infections (BSI), urinary tract infections (UTI), and others. UTI dominated the market in 2017. The segment is likely to maintain its position until 2025. The others segment, including pneumonia-causing organisms and antimicrobial-resistant bacteria, is poised to register remarkable CAGR over the forecast period.

According to facts published by womenshealth.gov, women are more susceptible to UTI by 30.0% as compared to men. Moreover, according to the CDC, 75.0% of UTIs acquired in hospitals are due to prolonged use of urinary catheters. In addition, the European Centre for Disease Prevention and Control states that among all patients treated in ICU for over 2 days, 3.0% suffered from UTIs.

End-use Insights

Based on end use, the market has been segmented into hospitals, long-term care centers, and others. In 2017, hospitals were the leading revenue contributor in the global arena. The higher share of hospitals can be attributed to their ability to manage the treatment of HAIs better, as more patients can be monitored within the stipulated time due to an increase in the number of surgeries.

Approximately, 45.0% of the hospitals use electronic surveillance systems, and it is expected to increase further as there is a need for quicker software tools for analysis of disease patterns. Automated tools analyze past infection trends through simulation techniques that help in containing disease outbreaks.

Regional Insights

North America, followed by Europe, is estimated to account for the leading share in the market through 2025. Strong government initiatives and rising incidence of HAIs in the U.S. and Canada are likely to stoke the growth of the regional market. For instance, the National Action Plan (NAP), a five-year action plan, was introduced to combat antibiotic-resistant bacteria, including the incidence of Carbapenem-resistant Enterobacteriaceae, Clostridium difficile, and methicillin-resistant Staphylococcus aureus.

The Asia Pacific market is expected to exhibit significant growth during the forecast period, owing to improving healthcare infrastructure and rising medical tourism. However, the high cost of systems and low awareness about the availability of advanced systems are some of the factors challenging the growth of the market in APAC.

Infection Surveillance Solutions Market Share Insights

Some of the prominent companies in the market are Becton, Dickinson and Company; Premier Inc.; Wolters Kluwer N.V; Gojo Industries; RL Solutions; Baxter International Inc.; Premier Inc.; and Truven Health Analytics (An IBM Company). These players are focusing on the launch of new products in the market. For instance, in September 2018, Wolters Kluwer introduced its new version of clinical surveillance solution Sentri7. This tool provides infection surveillance in hospitals to restrict antibiotic-resistant bacteria.

Infection Surveillance Solutions Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global infection surveillance solutions market report on the basis of product and services, infection type, end use, and region:

• Product and Services Outlook (Revenue, USD Million, 2014 - 2026)

  • Software

    • On-premise

    • Web-based

  • Services

• Infection Type Outlook (Revenue, USD Million, 2014 - 2026)

  • Surgical Site Infections (SSI)       

  • Blood Stream Infections (BSI)

  • Urinary Tract Infections (UTI)

  • Others           

• End-use Outlook (Revenue, USD Million, 2014 - 2026)

  • Long Term Care Facilities

  • Hospitals

  • Others (Clinics, and Ambulatory Surgical Centers)    

• Regional Outlook (Revenue, USD Million, 2014 - 2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia